---
title: "GuoTong revised its 2024 performance forecast, expecting a net loss of 272 million to 247 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236801491.md"
description: "GuoTong announced a revision of its 2024 annual performance forecast, expecting a net loss of 272 million to 247 million yuan. The company originally expected a net loss of 85 million to 60 million yuan"
datetime: "2025-04-21T12:58:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236801491.md)
  - [en](https://longbridge.com/en/news/236801491.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236801491.md)
generator: "portal-rs"
---

# GuoTong revised its 2024 performance forecast, expecting a net loss of 272 million to 247 million yuan

GuoTong announced a revision of its 2024 annual performance forecast, expecting a net loss of 272 million to 247 million yuan. The company originally expected a net loss of 85 million to 60 million yuan

### Related Stocks

- [002205.CN](https://longbridge.com/en/quote/002205.CN.md)

## Related News & Research

- [08:15 ETNow's the Time: Late Summer Is the Best Season For Homebuyers to Score a Deal in These U.S. Metros](https://longbridge.com/en/news/296616885.md)
- [10:07 ETOG Anunoby Wants You to Take Your Cat to the Vet](https://longbridge.com/en/news/296504396.md)
- [Rahman Hydraulic Tin Sdn Bhd To Temporarily Suspend Mining Operations](https://longbridge.com/en/news/296213949.md)
- [Eric Mausner and Justin Guido of Mausner Group Injury Lawyers Named to 2027 Best Lawyers in America(R)](https://longbridge.com/en/news/296525675.md)
- [FDA Gives Marketing Authorization to Vitestro's Robotic Blood Draw Device](https://longbridge.com/en/news/296405953.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**